Clinical trial
A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia
NCT00178113 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00178113 |
|---|---|
| Title | A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia |
| Official title | Phase I Clinical Trial: Randomized Lycopene Supplementation in Tobago Men With High-Grade Prostatic-Intraepithelial Neoplasia |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostatic Intraepithelial Neoplasia |
| Intervention type | Drug |
| Interventions | - Lyc-O-Mato (dietary supplement, 30 mg lycopene/day), - Certagen (multivitamins with minerals) |
| Enrollment | 80 |
| Start date | Jul 1, 2003 |
| Completion | Jul 1, 2004 |
| First posted | Sep 15, 2005 |
| Last update posted | May 27, 2015 |
| Countries | Trinidad and Tobago |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: